# Adjuvant Capital: portfolio, investments and team

> Adjuvant Capital is a vc firm based in United States. 4 investments on record, latest Nov 2019. Portfolio, stages, co-investors and team.

Source: https://millionrounds.com/fund/adjuvant-capital (Millionrounds; every figure on the page links to its filing or article)

United States · [Investor](https://millionrounds.com/investors)

# Adjuvant Capital

Last cheque observed Nov 2019. Silence since then is not evidence of inactivity: our sources miss unannounced rounds.

Email

Quiet New fund $48M, Feb 2021 VC firm

Seed Series A Series B Med Device Medtech Ivd

Follow Adjuvant Capital and see its new cheques in your feed. [Start following](https://millionrounds.com/login?join=1&why=follow&next=%2Ffund%2Fadjuvant-capital)

Cheques on record

**0%** of best year **0** **cheques in 12 months**, 4 on record

Since the last cheque **2537** days **00** hrs **00** min **00** sec

Median round **$28M** Cheque size, as they say **$100K – $300M** Rounds led **0 of 4** Sole investor **1 rounds**

Pitch Adjuvant Capital

## Adjuvant Capital highlights

- 01 4 rounds on record
- 02 Mostly Series A and Series D: 100% of its rounds
- 03 Sole investor in 1 rounds, median $7.0M

## What they do

> Adjuvant is a new type of venture capital firm. From their own website

- **Type:** VC firm (from a list, unverified)
- **Cheque size:** $100K – $300M as they say
- **Stages:** Seed Series A Series B Growth
- **Sectors:** Med Device Medtech Ivd
- **Based in:** New York Mills, United States
- **Cold pitches:** Not stated

## The record

Every round we can evidence, newest first **4 appearances**

- **2019** 4 rounds
- **Nov** **[AN2](https://millionrounds.com/company/an2)** Series A · US · FinSMEs **$12M** With 3 others
- **Sept** **[Themis](https://millionrounds.com/company/themis)** Series D · AT · FinSMEs **$44M** With 8 others
- **Sept** **[InDevR](https://millionrounds.com/company/indevr)** Series A · US · FinSMEs **$7.0M** Sole investor
- **Jul** **[X-Vax](https://millionrounds.com/company/x-vax)** Series A · US · FinSMEs **$56M** With 5 others

An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.

## The team

Named by the firm itself, on a filing, its Form ADV or its company registration **4 named**

EB **Evelyn Beth Yanatos** Director of Finance and Compliance; Chief Compliance Officer i Form ADV

GA **Glenn Anthony Rockman** Executive Officer i Filing they signed

JY **Jenny Yip** Executive Officer i Filing they signed

KA **Kabeer Aziz** Partner i Form ADV

We also hold **19** people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.

## What the register says

From the firm's own filings with the SEC, which it must file accurately by law

**$170M** gross assets of its funds Oct 2026

**Exempt** reporting adviser venture or small private funds

- **Legal name:** Adjuvant Capital, LP
- **SEC number:** CRD 301716

## What they claim to have backed

From their own portfolio page (on their website)

**9** of 17 we have independently watched raise

[54gene](https://millionrounds.com/company/54gene)[An2therapeutics](https://millionrounds.com/company/an2-therapeutics)[Antivabio](https://millionrounds.com/company/antiva-biosciences)[Chromacode](https://millionrounds.com/company/chromacode)[Evofem](https://millionrounds.com/company/evofem)[Frontiernutrition](https://millionrounds.com/company/frontier-nutrition)[Indevr](https://millionrounds.com/company/indevr)[Memo-therapeutics](https://millionrounds.com/company/memo-therapeutics)[Pulmocide](https://millionrounds.com/company/pulmocide) Curevovaccine Lakeshorebio Lmtbio Mangrove-web Quantoom Themisbio Vitrivaxbio excision.bio

Weaker than a round we watched, stronger than a list somebody sold us. A firm is far less willing to put a company on its own site that it never funded.

New fund on file

**$48M**

raised in Feb 2021

From its SEC filing, not a journalist: a firm that has just raised has money to deploy.

## The cheque

Seed Series A Series B

Median round joined **$28M** the round, not its cheque Alone, median **$7.0M**

Led 0 of 4 rounds **0%**

- **Said size:** $100K – $300M
- **Sole investor:** 1 rounds
- **Last cheque:** Nov 2019

Rounds by stage said on their site

- Series A said *3*
- Series D *1*
- Seed said *-*
- Series B said *-*
- Growth said *-*

**Pitching Adjuvant Capital?** Put them on your fundraising board with this record on the card, and follow them to hear when they write a new cheque.

Add to your CRM *→*

## Recently backed

The latest companies Adjuvant Capital put money into.

[**InDevR** $7.0M · Sept 2019](https://millionrounds.com/company/indevr)

## Mentioned on podcasts

Episodes that name Adjuvant Capital in their description, not their title.

- [The Full Ratchet](https://millionrounds.com/podcasts/full-ratchet) 17 May 2021 · 44 min 282. The Future of Public Health, VC Differentiation within Life Sciences, and Preventing the Next Pandemic (Glenn Rockman) With [Glenn Rockman](https://millionrounds.com/person/glenn-rockman) Mentions [Adjuvant Capital](https://millionrounds.com/fund/adjuvant-capital) Apple PodcastsShow page

## Quick answers about Adjuvant Capital

### What does Adjuvant Capital invest in?

Adjuvant Capital invests most often at Series A and Series D (100% of the rounds on record), in sectors such as Med Device, Medtech and Ivd.

### How active is Adjuvant Capital?

4 investments on record, 0 of them in the last 12 months. The most recent was in Nov 2019.

### What has Adjuvant Capital invested in recently?

Its most recent investments on record: AN2 (Series A, Nov 2019), Themis (Series D, Sept 2019) and InDevR (Series A, Sept 2019).

### How big are Adjuvant Capital's cheques?

The median round it joins is $28M. It says it writes cheques of $100K to $300M.

### Is Adjuvant Capital investing now?

No investments in the last 12 months; the latest was in Nov 2019.

### What kind of investor is Adjuvant Capital?

Adjuvant Capital is a VC firm based in New York Mills, United States.

### How much does Adjuvant Capital manage?

About $170M, as gross assets of its private funds (Oct 2026).

### Has Adjuvant Capital raised a new fund?

Its latest fund filing with the SEC was in Feb 2021, reporting $48M raised.

## Raising now?

Find the investors who back rounds like yours, and keep every conversation on one fundraising board.

Find similar investorsOpen your CRM

Built from the rounds we watched, its filings and its own website, refreshed every night. [How we count](https://millionrounds.com/methodology) · [Report a correction](https://millionrounds.com/corrections?slug=adjuvant-capital) · [Is this your firm? Claim it](https://millionrounds.com/claim?org=adjuvant-capital)
